Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON21690
NL-OMON21690
Recruiting
Not Applicable

Quantitative sensory testing and intraepidermal nerve fiber density for improved diagnosis of Fabry disease.

TIpharma consortiumAcademia: Amcpharma: Genzyme, a sanofy companysubsidizing party: Shire HGT0 sites25 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsFabry diseaseSmall fiber neuropathyDiagnosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fabry diseaseSmall fiber neuropathyDiagnosis
Sponsor
TIpharma consortiumAcademia: Amcpharma: Genzyme, a sanofy companysubsidizing party: Shire HGT
Enrollment
25
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
TIpharma consortiumAcademia: Amcpharma: Genzyme, a sanofy companysubsidizing party: Shire HGT

Eligibility Criteria

Inclusion Criteria

  • •Decrease in alpha\-galactosidase A activity in leucocytes, plasma or fibroblasts
  • •according to local laboratory criteria AND presence of a mutation in the alpha\-
  • •galactosidase A gene of uncertain clinical relevance.

Exclusion Criteria

  • •Patient is unwilling to participate.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Quantitative sensory testing and intraepidermal nerve fibre density for improved diagnosis of Fabry disease.Anderson-Fabry diseaseFabry disease10027424
NL-OMON37662Academisch Medisch Centrum30
Completed
Not Applicable
Evaluation of the Sensitivity of a Transdermal Device to Monitor the Sweat Alcohol ConcentrationThe Sweat Alcohol Concentration
NCT02860195Assistance Publique Hopitaux De Marseille6
Completed
Not Applicable
*Characteristics of Quantitative Sensory Testing in ACNES patients compared to healthy controls; a pilot study.*abdominal wall painentrapment neuropathy10034606
NL-OMON43275Maxima Medisch Centrum40
Recruiting
Not Applicable
Validation study of a new quantitative sensory testing device "intercross-220"
JPRN-UMIN000045701Others30
Recruiting
Not Applicable
The role of sensory parameters in predicting clinical outcome after lumbar discectomyNeurological - Other neurological disordersumbar radiculopathy with radicular painLumbar radiculopathy with radicular painSurgery - Other surgery
ACTRN12614001070628Dr Brigitte Tampin160